BioSpace News Archive

Biotech Bay

Codexis to Participate in Four Investment Conferences in November 2019

Codexis, Inc., a leading protein engineering company, announces that management will participate in four upcoming investment conferences

November 5, 2019
·
1 min read
Business

Chimerix Announces Third Quarter 2019 Financial Results and Provides Operational Update

Final Data from Phase 2 Randomized Trial of DSTAT in First-line AML Support Enhanced Durability of Response, Event-free Survival and Overall Survival Benefit

November 5, 2019
·
9 min read
Neovasc to Provide Update on TF/TS Tiara Program at PCR Valves 2019

Neovasc, Inc. announced that the company will be providing an update on its Transfemoral Trans-septal Tiara System at the PCR London Valves 2019 meeting, which takes place November 17-19 in London.

November 5, 2019
·
4 min read
Business

Oxford Immunotec Reports Third Quarter 2019 Financial Results

Oxford Immunotec Global PLC announced third quarter 2019 financial results.

November 5, 2019
·
8 min read
Drug Development

Evelo Biosciences Reports Further Positive EDP1815 Interim Clinical Data in Patients with Psoriasis at High Dose in Phase 1b Trial

Evelo Biosciences announced positive interim clinical data in an ongoing Phase 1b trial in individuals with mild to moderate psoriasis treated with a high dose of EDP1815, its clinical candidate for the treatment of a range of inflammatory diseases.

November 5, 2019
·
10 min read
Business

resTORbio Reports Third Quarter 2019 Financial Results and Corporate Update

resTORbio, Inc., a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, provided a corporate update and reported financial results for the third quarter ended September 30, 2019.

November 5, 2019
·
10 min read
Opsens Announces Entry Into Structural Heart Market

Opsens Inc. announces it is expanding its medical device business into the structural cardiology space and will accelerate development activities of products that reach beyond its current coronary and peripheral applications..

November 5, 2019
·
2 min read
Policy

Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine

Anixa Biosciences, Inc., a biotechnology company focused on harnessing the body’s immune system in the fight against cancer, announced that the United States Patent and Trademark Office has issued US Patent No. 10,463,724 titled “Breast Cancer Vaccine.”

November 5, 2019
·
3 min read
Business

Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Viking Therapeutics, Inc. announced its financial results for the third quarter ended September 30, 2019, and provided an update on its clinical pipeline and other corporate developments.

November 5, 2019
·
12 min read
Business

Curis Reports Third Quarter 2019 Financial Results

Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported its financial results for the third quarter ended September 30, 2019.

November 5, 2019
·
14 min read